Cargando…
The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?
Drug-induced liver injury (DILI) is a potentially fatal adverse event and the leading cause of acute liver failure in the US and in the majority of Europe. The liver can be affected directly, in a dose-dependent manner, or idiosyncratically, independently of the dose, and therefore unpredictably. Cu...
Autores principales: | Iruzubieta, Paula, Arias-Loste, Maria Teresa, Barbier-Torres, Lucía, Martinez-Chantar, Maria Luz, Crespo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707380/ https://www.ncbi.nlm.nih.gov/pubmed/26824035 http://dx.doi.org/10.1155/2015/386186 |
Ejemplares similares
-
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
por: Del Barrio, María, et al.
Publicado: (2023) -
LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019) -
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
por: Santos-Laso, Alvaro, et al.
Publicado: (2021) -
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
por: Alonso-Peña, Marta, et al.
Publicado: (2023) -
A morphological method for ammonia detection in liver
por: Gutiérrez-de-Juan, Virginia, et al.
Publicado: (2017)